Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$573M |
| 2 |
Microsoft
MSFT
|
+$529M |
| 3 |
McDonald's
MCD
|
+$469M |
| 4 |
Walt Disney
DIS
|
+$303M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$291M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$482M |
| 2 |
Comcast
CMCSA
|
+$481M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$381M |
| 4 |
Sherwin-Williams
SHW
|
+$374M |
| 5 |
CELG
Celgene Corp
CELG
|
+$341M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.22% |
| 2 | Technology | 7.41% |
| 3 | Consumer Discretionary | 6.04% |
| 4 | Financials | 5.89% |
| 5 | Industrials | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ARNA
6876
PUT
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $49K | ﹤0.01% |
3,390
-80
| -2% | -$1.19K |
2016 Q4
1 quarter
|
|
6877
Gerdau
GGB
$9.83B
| $48K | ﹤0.01% |
17,639
-86,945
| -83% | -$270K |
2015 Q3
6 quarters
|
|
6878
Performance Shipping
PSHG
$21M
| – | – |
0
| – | – |
2016 Q3
2 quarters
|
|
6879
CALL
QuickLogic
QUIK
$217M
| $48K | ﹤0.01% |
+1,914
| New | +$43.8K |
2017 Q1
0 quarters
|
|
|
AGFS
6880
DELISTED
AgroFresh Solutions Inc
AGFS
| $48K | ﹤0.01% |
10,880
-17,674
| -62% | -$52.4K |
2016 Q4
1 quarter
|
|
|
RBCN
6881
DELISTED
Rubicon Technology, Inc.
RBCN
| $48K | ﹤0.01% |
5,776
+3,928
| +213% | +$23.3K |
2016 Q4
1 quarter
|
|
|
MOBL
6882
PUT
DELISTED
MobileIron, Inc.
MOBL
| $48K | ﹤0.01% |
11,000
-4,300
| -28% | -$19K |
2016 Q3
2 quarters
|
|
|
ARLZ
6883
PUT
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
| $48K | ﹤0.01% |
22,500
-6,600
| -23% | -$24.8K |
2016 Q3
2 quarters
|
|
6884
CALL
Ceragon Networks
CRNT
$199M
| $47K | ﹤0.01% |
+14,300
| New | +$50.8K |
2017 Q1
0 quarters
|
|
|
RTC
6885
DELISTED
Baijiayun Group
RTC
| $47K | ﹤0.01% |
+2,785
| New | +$40.7K |
2017 Q1
0 quarters
|
|
|
TVIA
6886
PUT
DELISTED
TerraVia Holdings, Inc. Common Stock
TVIA
| $47K | ﹤0.01% |
65,200
+1,600
| +3% | +$1.49K |
2016 Q2
3 quarters
|
|
|
ASM
6887
Avino Silver & Gold Mines
ASM
$943M
| $46K | ﹤0.01% |
+26,414
| New | +$45.6K |
2017 Q1
0 quarters
|
|
|
HEPA
6888
DELISTED
Hepion Pharmaceuticals
HEPA
| – | – |
0
| – | – |
2017 Q1
0 quarters
|
|
6889
PUT
Intrepid Potash
IPI
$441M
| $46K | ﹤0.01% |
2,680
-2,240
| -46% | -$43.3K |
2016 Q3
2 quarters
|
|
6890
CALL
McEwen Inc
MUX
$1.09B
| $46K | ﹤0.01% |
1,500
-2,740
| -65% | -$98.8K |
2015 Q4
5 quarters
|
|
|
IPAS
6891
DELISTED
Ipass Inc Common Stock
IPAS
| $46K | ﹤0.01% |
3,899
+2,836
| +267% | +$38.8K |
2016 Q4
1 quarter
|
|
|
ABAC
6892
DELISTED
Renmin Tianli Group, Inc. Common Shares
ABAC
| $46K | ﹤0.01% |
+19,859
| New | +$61.2K |
2017 Q1
0 quarters
|
|
|
RPRX
6893
CALL
DELISTED
Repros Therapeutics Inc.
RPRX
| $46K | ﹤0.01% |
38,500
+12,500
| +48% | +$15.6K |
2016 Q2
3 quarters
|
|
|
ATXS
6894
DELISTED
Astria Therapeutics
ATXS
| $45K | ﹤0.01% |
+466
| New | +$64.2K |
2017 Q1
0 quarters
|
|
6895
PUT
Rocket Pharmaceuticals
RCKT
$281M
| $45K | ﹤0.01% |
5,675
-725
| -11% | -$4.88K |
2016 Q4
1 quarter
|
|
|
ASXC
6896
DELISTED
Asensus Surgical, Inc.
ASXC
| $45K | ﹤0.01% |
2,869
+811
| +39% | +$14.1K |
2016 Q4
1 quarter
|
|
|
CORI
6897
DELISTED
Corium International, Inc.
CORI
| $45K | ﹤0.01% |
+10,759
| New | +$39.5K |
2017 Q1
0 quarters
|
|
6898
PUT
ClearSign Technologies
CLIR
$23.9M
| $44K | ﹤0.01% |
1,130
-210
| -16% | -$7.59K |
2016 Q3
2 quarters
|
|
|
6899
Rocket Pharmaceuticals
RCKT
$281M
| $44K | ﹤0.01% |
5,490
-1,329
| -19% | -$8.94K |
2016 Q4
1 quarter
|
|
6900
SuperCom
SPCB
$59.1M
| $44K | ﹤0.01% |
+77
| New | +$51.3K |
2017 Q1
0 quarters
|
|
Similar funds
Citadel Advisors's Q1 2017 Portfolio in Review
As of Q1 2017, Citadel Advisors held 8,634 positions worth $109B, up 11% from $99B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Citadel Advisors deployed $4.43B of net new capital in Q1 2017, opening 1,445 new positions and adding to 2,647 existing holdings. Its largest new stake was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, down from 63% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $482M trimmed.
- Citadel Advisors's largest Q1 2017 buy was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
- Citadel Advisors added most to Microsoft in Q1 2017, an estimated $529M increase.
- Citadel Advisors's biggest Q1 2017 reduction was Alphabet (Google) Class A, cutting an estimated $482M.
- Citadel Advisors fully exited Celgene Corp in Q1 2017, selling an estimated $341M.
- Citadel Advisors's ten largest holdings make up 19% of its $109B portfolio in Q1 2017.
- Citadel Advisors opened 1,445 new positions and closed 1,267 in Q1 2017.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $109B.
Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.